Home
About
About Anagenics
Board of Directors
Divisions
Our Divisions
Beauty
Brands
évolis®
Uspa
Investors
Investor Centre
ASX Announcements
2024
2023
2022
2021
2020
2019
Financial Information & Reports
Share Registry Information
Analyst Coverage
Share Information
Anagenics in the media
Newsletter Archive
Corporate Governance
Corporate Governance
Board Charter
Code of Conduct
Policies
Audit Committee Charter
Nomination and Remuneration Committee Charter
Performance Evaluation Process
Corporate Code of Conduct
Environmental, Social and Governance Statement
✕
2010
Home
2010
November 18, 2019
Published by
Tiffany McMillan
on
November 18, 2019
Categories
Joint Research Agreement Signed with Kumamoto University
November 18, 2019
Published by
Tiffany McMillan
on
November 18, 2019
Categories
Appendix 3B
November 18, 2019
Published by
Tiffany McMillan
on
November 18, 2019
Categories
Appendix 4C
November 18, 2019
Published by
Tiffany McMillan
on
November 18, 2019
Categories
Appendix 3B
November 18, 2019
Published by
Tiffany McMillan
on
November 18, 2019
Categories
Preclinical Study Shows Reduction in Disease Severity
November 18, 2019
Published by
Tiffany McMillan
on
November 18, 2019
Categories
Cellmid Secures US$8M Funding
November 18, 2019
Published by
Tiffany McMillan
on
November 18, 2019
Categories
Notice of Annual General Meeting / Proxy Form
November 18, 2019
Published by
Tiffany McMillan
on
November 18, 2019
Categories
Annual Report to Shareholders
November 18, 2019
Published by
Tiffany McMillan
on
November 18, 2019
Categories
Cellmid Launches Lifesyle Subsidiary
Prev page
1
2
3
Next page
